Navidea Envisions a World Where Disease can be Precisely Identified and Treated

Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a leader in precision medicine with immuno-targeted products designed to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making, targeted treatment and, ultimately, patient care.

Applying our Manoceptâ„¢ technology, Navidea seeks to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases.

Learn More

Latest Event

Dec 16, 2021 • 5:00pm EST

Navidea Biopharmaceuticals Business Update

View All Events

Navidea Biopharmaceuticals, Inc.


NYSE American: NAVB




Day Range

Year Range